FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2950646945> ?p ?o ?g. }

• W2950646945 abstract "Background: Recent studies suggest that patients with lupus have higher rates of cervical dysplasia and pre-malignant lesions. We have a large population of lupus patients at our institution that may be at increased risk of dysplastic lesions due to suboptimal rates of HPV vaccination and cervical cancer screening. The aim of this study was to determine the rate of HPV vaccination completion and cervical cancer screening compliance among the lupus patients seen in our institution. In addition, we developed a process to increase patient education and improve both HPV and cervical cancer screening rates at the level of the outpatient renal, dermatology and rheumatology clinics. Objectives: To improve rates of cervical cancer screening and HPV vaccination among patients with Lupus Methods: A comprehensive list was compiled of all patients with a diagnosis of lupus seen in the clinics over a 3 year period. A chart review of 332 patients was subsequently performed to determine the rate of HPV vaccination completion and the rate of compliance with cervical cancer screening. Methods were developed to improve these rates by streamlining access to HPV vaccination sites or facilitating referral for screening exams. Patients were also provided education through brochures about their increased risk. Results: Our results revealed that rates of HPV vaccination among lupus patients at our institution were lower than national averages by 11%. Rates of cervical cancer screening were also 21% lower compared to national average for this group of patients. In creating a system to flag providers and increase patient education, we were able to improve these rates. In the first two months, 73.7% of all patients seen in the clinics were provided education and 61.5% of eligible patients that were seen in clinic were appropriately referred to either their PCP or to gynecology to complete cervical cancer screening and prevention. Conclusion: Initial review of the lupus population at our institution highlighted a strong need to develop an intervention to improve vaccination and screening compliance in this population. By raising awareness amongst providers, we were able to significantly increase the number of at risk patients referred for cervical cancer screening and prevention. Given that the United States Food and Drug Administration has recently approved to expand the use of the HPV vaccine to women and men up to age 45, future efforts will be made to expand our eligble population to reflect these recommendations. References [1] “FDA Approves Expanded Use of Gardasil 9 to Include Individuals 27 through 45 Years Old.” FDA News Release, 5 Oct. 2018, www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm622715.htm. [2] “Gynecologic Cancers.” Centers for Disease Control and Prevention, 27 June 2018, www.cdc.gov/cancer/cervical/basic_info/test-results.htm. [3] “Practice Bulletin No. 140.” Obstetrics & Gynecology, vol. 122, no. 6, 2013, pp. 1338–1366., doi:10.1097/01.aog.0000438960.31355.9e. [4] “Vaccines & Immunizations.” Centers for Disease Control and Prevention, 4 Sept. 2018, www.cdc.gov/vaccines/index.html. [5] Feldman, C H, et al. “Risk of High-Grade Cervical Dysplasia and Cervical Cancer in Women with Systemic Lupus Erythematosus Receiving Immunosuppressive Drugs.” Lupus, vol. 26, no. 7, 2016, pp. 682–689., doi:10.1177/0961203316672928. [6] Grein, Ingrid Herta Rotstein, et al. “HPV Infection and Vaccination in Systemic Lupus Erythematosus Patients: What We Really Should Know.” Pediatric Rheumatology, vol. 14, no. 1, 2016, doi:10.1186/s12969-016-0072-x. [7] Santana, I U, et al. “Systemic Lupus Erythematosus, Human Papillomavirus Infection, Cervical Pre-Malignant and Malignant Lesions: a Systematic Review.” Clinical Rheumatology., May 2011 Disclosure of Interests: Nancy Desai: None declared, Michael York: None declared, Hanni Menn-Josephy: None declared, Ramon Bonegio Grant/research support from: Merck, Chugai Pharmaceuticals, Astra Zeneca, Aurinia Pharmacueticals, Consultant for: Merck, Chugai Pharmaceuticals, Christina Lam: None declared, Anna Kancharla: None declared" @default.
• W2950646945 created "2019-06-27" @default.
• W2950646945 creator A5026560160 @default.
• W2950646945 creator A5029753583 @default.
• W2950646945 creator A5036233852 @default.
• W2950646945 creator A5039308003 @default.
• W2950646945 creator A5056183703 @default.
• W2950646945 creator A5060654129 @default.
• W2950646945 date "2019-06-01" @default.
• W2950646945 modified "2023-09-26" @default.
• W2950646945 title "AB0502 IMPROVING RATES OF CERVICAL CANCER SCREENING AND PREVENTION IN PATIENTS WITH LUPUS" @default.
• W2950646945 cites W2119837784 @default.
• W2950646945 doi "https://doi.org/10.1136/annrheumdis-2019-eular.6028" @default.
• W2950646945 hasPublicationYear "2019" @default.
• W2950646945 type Work @default.
• W2950646945 sameAs 2950646945 @default.
• W2950646945 citedByCount "0" @default.
• W2950646945 crossrefType "proceedings-article" @default.
• W2950646945 hasAuthorship W2950646945A5026560160 @default.
• W2950646945 hasAuthorship W2950646945A5029753583 @default.
• W2950646945 hasAuthorship W2950646945A5036233852 @default.
• W2950646945 hasAuthorship W2950646945A5039308003 @default.
• W2950646945 hasAuthorship W2950646945A5056183703 @default.
• W2950646945 hasAuthorship W2950646945A5060654129 @default.
• W2950646945 hasBestOaLocation W29506469451 @default.
• W2950646945 hasConcept C121608353 @default.
• W2950646945 hasConcept C126322002 @default.
• W2950646945 hasConcept C131872663 @default.
• W2950646945 hasConcept C203014093 @default.
• W2950646945 hasConcept C22070199 @default.
• W2950646945 hasConcept C2776912625 @default.
• W2950646945 hasConcept C2778220009 @default.
• W2950646945 hasConcept C2779134260 @default.
• W2950646945 hasConcept C2908647359 @default.
• W2950646945 hasConcept C530470458 @default.
• W2950646945 hasConcept C71924100 @default.
• W2950646945 hasConcept C99454951 @default.
• W2950646945 hasConceptScore W2950646945C121608353 @default.
• W2950646945 hasConceptScore W2950646945C126322002 @default.
• W2950646945 hasConceptScore W2950646945C131872663 @default.
• W2950646945 hasConceptScore W2950646945C203014093 @default.
• W2950646945 hasConceptScore W2950646945C22070199 @default.
• W2950646945 hasConceptScore W2950646945C2776912625 @default.
• W2950646945 hasConceptScore W2950646945C2778220009 @default.
• W2950646945 hasConceptScore W2950646945C2779134260 @default.
• W2950646945 hasConceptScore W2950646945C2908647359 @default.
• W2950646945 hasConceptScore W2950646945C530470458 @default.
• W2950646945 hasConceptScore W2950646945C71924100 @default.
• W2950646945 hasConceptScore W2950646945C99454951 @default.
• W2950646945 hasLocation W29506469451 @default.
• W2950646945 hasOpenAccess W2950646945 @default.
• W2950646945 hasPrimaryLocation W29506469451 @default.
• W2950646945 hasRelatedWork W1969646978 @default.
• W2950646945 hasRelatedWork W2053624364 @default.
• W2950646945 hasRelatedWork W2089251701 @default.
• W2950646945 hasRelatedWork W2110059710 @default.
• W2950646945 hasRelatedWork W2330743116 @default.
• W2950646945 hasRelatedWork W2463084518 @default.
• W2950646945 hasRelatedWork W2566472323 @default.
• W2950646945 hasRelatedWork W2594361503 @default.
• W2950646945 hasRelatedWork W2760130894 @default.
• W2950646945 hasRelatedWork W2765104972 @default.
• W2950646945 hasRelatedWork W2790315226 @default.
• W2950646945 hasRelatedWork W2951565931 @default.
• W2950646945 hasRelatedWork W2954507768 @default.
• W2950646945 hasRelatedWork W2995417993 @default.
• W2950646945 hasRelatedWork W3014709820 @default.
• W2950646945 hasRelatedWork W3017917078 @default.
• W2950646945 hasRelatedWork W3045996770 @default.
• W2950646945 hasRelatedWork W3103384443 @default.
• W2950646945 hasRelatedWork W3163318605 @default.
• W2950646945 hasRelatedWork W3194734873 @default.
• W2950646945 isParatext "false" @default.
• W2950646945 isRetracted "false" @default.
• W2950646945 magId "2950646945" @default.
• W2950646945 workType "article" @default.